Effects of granisetron and lorazepam, alone and in combination, on the EEG of human volunteers.
- 1 January 1991
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 31 (1) , 93-97
- https://doi.org/10.1111/j.1365-2125.1991.tb03863.x
Abstract
1. The EEG effects of granisetron, a potent and selective 5‐HT3 receptor antagonist (160 micrograms kg‐1), and lorazepam (2.5 mg) were examined in 12 healthy male volunteers. 2. The results indicated that lorazepam had a marked effect on the CNS, significantly increasing power in the slow (1‐7 Hz) and fast (13‐20 Hz; 21‐30 Hz) wavebands whilst reducing power in the mid range (8‐12 Hz). 3. In contrast there was no demonstrable effect of granisetron on the EEG at the dose tested, and no evidence of a pharmacodynamic interaction between the two compounds.Keywords
This publication has 5 references indexed in Scilit:
- Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacoprideJournal of Pharmacy and Pharmacology, 1988
- Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonismBritish Journal of Pharmacology, 1986
- Spectral difference index: A single EEG measure of drug effectElectroencephalography and Clinical Neurophysiology, 1982
- EEG and Human PsychopharmacologyAnnual Review of Pharmacology, 1969
- On Methods in the Analysis of Profile DataPsychometrika, 1959